Investors
Subscribe below to keep up to date with our progress
Latest Announcements
December 2022
Provisional Patent Application: Natural MedTech Submit Precision Fermentation Provisional Patent "Methods for the production of tryptophan derivatives"
November 2022
Provisional Patent Application: Natural MedTech submit a provisional patent "Psychedelic Formulations and Uses"
October 2022
Natural MedTech appoints Luke McFarlane as Managing Director
September 2022
Natural MedTech Appoints Peter Schubert as
Chairman
June 2022
Natural MedTech Signs Research Agreement to Study How Psychedelics Impact Neurodevelopment
April 2022
Natural Medtech Collaborates with the University of South Australia to Develop Novel Drug Delivery Formulation
March 2022
Natural MedTech Receives Permit to import Psychedelic Drugs into Australia
March 2022
Natural MedTech purchases GMP Psychedelics for Formulation of Novel Dosage Forms
March 2022
Natural MedTech Receives its Schedule 8 or Schedule 9 Poisons Licence to sell or supply and Research Psychedelics